SCLC ClinicalImpact: New Tools and Expert Guidance for Integrating Immunotherapies

Download All
Get expert insights on the optimal integration of immunotherapies in the treatment of small-cell lung cancer with expert-authored commentaries, a series of 10 brief interactive videos with downloadable slidesets, and a new Interactive Decision Support Tool with expert recommendations individualized to your specific patient scenarios.
Anne Chiang, MD, PhD
Nicolas Girard, MD, PhD
Taofeek K. Owonikoko, MD, PhD

ClinicalThought

Read my thoughts on the importance of using combination chemoimmunotherapy as first-line treatment for extensive-stage SCLC.

Taofeek K. Owonikoko, MD, PhD Released: October 13, 2020

Do you know about the key clinical trials in relapsed extensive-stage small-cell lung cancer presented at WCLC 2020?

Nicolas Girard, MD, PhD Released: March 1, 2021

Read this expert commentary for an overview of our new treatment decision support tool for extensive-stage small-cell lung cancer, which provides treatment recommendations from 5 lung cancer experts for your patients with newly diagnosed and relapsed/refractory disease.

Anne Chiang, MD, PhD Released: May 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue